) enVista Aspire™ — A monofocal IOL for the modern world | Bausch + Lomb Surgical

Elevate the everyday

Transcend the boundaries of standard monofocals and deliver your patients an IOL designed for the modern world — a fusion of uncompromised distance vision with an optic designed for a broader depth of focus.

 

Intermediate Optimized monofocal IOLs

Built on innovative, Intermediate Optimized (IO) optics and harmonized with Controlled Curvature Change (3C) technology, enVista Aspire™ is a right option for your patients as they navigate their increasingly tech-infused lifestyles.

Proven platform and optical heritage

  • Novel optics built on a proven platform that is trusted around the world with more than 8 million implantations.
  • In optical bench testing, enVista Aspire™ demonstrated a broader depth of focus compared to enVista™ AO (Advanced Optics) monofocal IOLs.
  • The original glistening-free optic material.

Outstanding optical performance

Uncompromising distance vision.

In optical bench testing for enVista Aspire™ (Intermediate Optimized Optic) showed an Expected Visual Acuity (EVA) of 20/20 for distance vision.

enVista Aspire™ demonstrated similar depth of focus compared to TECNIS Eyhance™.

 

Decentration tolerance

Decentration is much more frequent than one might think.

In optical bench testing enVista Aspire™ is less sensitive to tilt and decentration when compared with TECNIS Eyhance™.

 

Removing cataracts. Correcting astigmatism. Both at the same time.

Thanks to our extended range of cyls and ultra-low +0.90 D, enVista Aspire™ Toric covers 68% of the cataract surgery population with > +0.50 D of corneal astigmatism.*

 

Lock in rotational stability you can count on

Accuset™ Haptics — designed for refractive predictability and stable centration. 100% of eyes ≤ 5° rotation.

enVista™ Toric delivered proven rotational stability from visit 1–2 months to visit 4–6 months.

 

Product Information

MATERIAL

  • Hydrophobic acrylic glistening-free
  • UV filter (10 % cut-off wavelength: 389 nm)
  • Refractive index: 1.53 at 35°C

DESIGN

  • Intermediate Optimized Toric IOL with posterior high order aspheric surface
  • One piece, biconvex
  • Modified C-loop haptic design
  • 360° posterior square edge
  • Haptic with fenestration holes
  • Optic diameter: 6.00 mm
  • Overall diameter: 12.50 mm

DIOPTER RANGE
enVista AspireTM
From +6.00 D to +34.00 D (0.50 D steps)

enVista AspireTM TORIC
Spherical equivalent power:
From +6.00 D to +34.00 D (0.50 D steps)

Cylinder power – IOL Plane: 0.90 D / +1.25 D / +1.50 D / +2.00
D / +2.50 D / +3.00 D / +3.50 D / +4.25 D / +5.00 D / +5.75 D

Cylinder power - Corneal plane: +0.64 D / +0.90 D / +1.06 D /
+1.40 D / +1.76 D / +2.11 D / +2.45 D / +2.98 D / +3.50 D / +4.03 D

DELIVERY SYSTEM
Non-preloaded
BLIS (screw type, controlled delivery) reusable inserter and single
use cartridge
Inserter: BLIS-R1 (1 Unit/box)
Cartridge: BLIS-X1 (10 Units/box)
Recommended incision size ≥ 2.2 mm
INJ100 (Silicone tip, push type single handed)
Single-use inserter: INJ100 (10 Units/box)
Recommended incision size ≥ 2.2 mm

CONSTANTS*
OPTIC CONSTANT
SRK/T Constant A: 119.1
ACD: 5.61
Surgeon factor: 1.85
Haigis: a0: 1.46 / a1: 0.40 / a2: 0.10

ULTRASONIC CONSTANT
Constant A: 118.7
ACD: 5.37
Surgeon factor: 1.62

* Constants are estimates only. It is recommended that each surgeon develops their own values.

ADDITIONAL PRODUCT INFORMATION

References

1. UnitedHealthcare. UnitedHealthcare Screen Time Report 2020. Published 2020. Accessed October 17, 2023. Available at: www.uhc.com
content/dam/uhcdotcom/en/BrokersAndConsultants/UnitedHealthcare- Screen-Time-Report-2020.pdf
2. enVista® and Enhanced enVista® shipments extract 2011-June 2024
3. enVista AspireTM Instructions for use, Figure 2.
4. BAUSCH+LOMB data on file: Aspire Optical Characterization Rev A - December 2022.
5. Juan Antonio Azor, Fidel Vega, Jesus Armengol, Maria S. Millan. Characterization of various presbyopia-correcting intraocular lenses on optical bench. Comparative study. Grupo
de Optica Aplicada y Procesado de Imagen (GOAPI). Department of Optics and Optometry Universitat Politecnica de Catalunya BARCELONATECH
6. Alarcon A, Canovas C, Rosen R, et al. Preclinical metrics to predict through-focus visual acuity for pseudophakic patients. Biomed Opt Express. 2016;7(5):1877-1888
7. American National Standards Institute (ANSI) Z80.35-2018, “Extended depth of focus intraocular lenses”
8. Vega F., Met al “Visual acuity of pseudophakic patients predicted from in-vitro measurements of intraocular lenses with different design,” Biomed. Opt. Express 9(10),4893–4906
(2018)
9. Harrer A., Hirnschall N., Tabernero J et al : Variability in angle k and its influence on higher-order aberrations in pseudophakic eyes J Cataract Refract Surg 2017; 43:1015–1019
10. Lake JC, Victor G, Clare G, et al. Toric intraocular lens versus limbal relaxing incisions for corneal astigmatism after phacoemulsification. Cochrane Database Syst Rev.
2019;12(12):CD012801. doi: 10.1002/14651858. CD012801.pub2
11. De Bernardo M, Zeppa L, Cennamo M, Iaccarino S, Zeppa L, Rosa N. Prevalence of Corneal Astigmatism before Cataract Surgery in Caucasian Patients. European Journal of
Ophthalmology. 2014;24(4):494-500. doi:10.5301/ejo.5000415
12. Miller AD, Kris MJ, Griffiths AC. Effect of small focal errors on vision. Optom Vis Sci. 1997;74(7):521-526. Novis C. Astigmatism and Toric Intraocular Lenses. Current Opinion in
Ophthalmology 2000; Vol. 11, Issue 1: 47-50.
13. Parker et al. Safety and effectiveness of a glistening-free single-piece hydrophobic acrylic intraocular lens (enVista). Clin Ophthalmol. 2013:7 1905–1912.
14. P. Heiner et al. Safety and effectiveness of a single-piece hydrophobic acrylic intraocular lens (enVista®) – results of a European and Asian-Pacific study. Clin Ophthalmol. 2014:8
629–635.
15. Garzon et al. Evaluation of Visual Outcomes After Implantation of Monofocal and Multifocal Toric Intraocular Lenses. J Refract Surg. 2015;31(2):90-97.
16. BAUSCH + LOMB data on file : Intraocular lens design verification report- July 2016.
17. BAUSCH + LOMB data on file: IOL competitive benchmarking study report_DEC 2009.
18. PMA P980040/S039: FDA Summary of Safety and Effectiveness Data_Tecnis Toric IOL.
19. enVista Toric data (MX60T). Packer M, Williams JI, Feinerman G, Hope RS. Prospective multicenter clinical trial to evaluate the safety and effectiveness of a new glistening-free onepiece
acrylic toric intraocular lens. Clinical Ophthalmology 2018:12 1031-1039
20. evoiolcalculator.com/start.aspx
21. Pantanelli SM, Sun A, Kansara N, Smits G. Comparison of Barrett and Emmetropia Verifying Optical Toric Calculators. Clin Ophthalmol. 2022;16:177-182https://doi.org/10.2147/
OPTH.S346925

Contact